Paclitaxel polilumex
Jump to navigation
Jump to search
| Paclitaxel polilumex | |
|---|---|
| Term | Paclitaxel polilumex |
| Short definition | paclitaxel albumin stabilized nanoparticle formulation - (pronounced) (PA-klih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kul for-myoo-LAY-shun) form of the cancer drug paclitaxel used alone or with other medicines to treat certain types of breast cancer, non-small cell lung cancer, and pancreatic cancer. Paclitaxel albumin-stabilized nanoparticle formulation may have fewer side effects and work better than other forms of paclitaxel. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
paclitaxel polilumex - (pronounced) (PA-klih-TAK-sil PAH-lee-GLOO-mex) A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of so-called mitotic inhibitors. Also called CT-2103, paclitaxel polyglutamate and xyotax
External links
- Medical encyclopedia article on Paclitaxel polilumex
- Wikipedia's article - Paclitaxel polilumex
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski